Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia
Abstract
Keywords
References
Marengo-Rowe AJ. The thalassemias and related disorders. Proc (Bayl Univ Med Cent). 2007;20(1):2731.
Langhi D, Ubiali EMA, Marques JFC, et al. Guidelines on Beta-thalassemia major regular blood transfusion therapy: Associao Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associao Mdica Brasileira 2016. Rev Bras Hematol Hemoter. 2016;38(4):3415.
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present, and future. Biochim Biophys Acta. 2010;1800(8):7609.
Puliyel M, Sposto R, Berdoukas VA, et al. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol. 2014;89(4):391-4.
Echeverria JMA, Castiella A, Emparanza JI. Quantification of iron concentration in the liver by MRI. Insights Imaging. 2012;3(2):173-80.
Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major ?-thalassemia. Iran J Ped Hematol Oncol. 2014;4(1):17-21.
Saggar K, Sobti P. MRI assessment of iron overload in thalassemia: an overview. Endo-Thal. 2013;11(1):29-36.
Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging. 2014;40(5):1003-21.
Leonardi B, Margossian R, Colan SD, Powell AJ. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging. 2008;1(5):572-8.
Noetzli LJ, Papudesi J, Coates TD, Wood JC. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood. 2009;114(19):4021-6.
Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 2008;112(7):2973-8.
Belmont A, Kwiatkowski JL. Deferiprone for the treatment of transfusional iron overload in thalassemia. Expert Rev Hematol. 2017;10(6):493-503.
Berdoukas V, Farmaki K, Carson S, Wood J, Coates T. Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Med. 2012;3:119-29.
Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010;18(3):359-ix.
Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol. 2007;13(35):4755-60.
Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, Wood JC. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2012;87(2):155-60.
de Montalembert M, Ribeil JA, Brousse V, et al. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. PLoS One. 2017;12(3):e0172147.
McLaren CE, Li KT, Gordeuk VR, Hasselblad V, McLaren GD. Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood. 2001;98(8):2345-51.
Refbacks
- There are currently no refbacks.